{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T12:26:55Z","timestamp":1791116815253,"version":"4.1.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,22]],"date-time":"2013-08-22T00:00:00Z","timestamp":1377129600000},"content-version":"vor","delay-in-days":478,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"NIH"},{"DOI":"10.13039\/100000887","name":"Huntington Disease Society of America","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000887","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1016\/j.bbadis.2011.11.014","type":"journal-article","created":{"date-parts":[[2011,11,23]],"date-time":"2011-11-23T14:17:09Z","timestamp":1322057829000},"page":"664-674","source":"Crossref","is-referenced-by-count":141,"title":["Antioxidants in Huntington's disease"],"prefix":"10.1016","volume":"1822","author":[{"given":"Ashu","family":"Johri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Flint","family":"Beal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2011.11.014_bb0005","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nature05778","article-title":"OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells","volume":"447","author":"Kovtun","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0010","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1750-3639.1997.tb00892.x","article-title":"Clinical aspects of CAG repeat diseases","volume":"7","author":"Nance","year":"1997","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0015","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1097\/00005072-199805000-00001","article-title":"Huntington disease","volume":"57","author":"Vonsattel","year":"1998","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0020","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1602\/neurorx.1.4.394","article-title":"Cell therapy in Huntington's disease","volume":"1","author":"Dunnett","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0025","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0030","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1212\/01.wnl.0000204230.16619.d9","article-title":"The association of CAG repeat length with clinical progression in Huntington disease","volume":"66","author":"Rosenblatt","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0705","series-title":"The Metabolic and Molecular Basis of Inherited Disease","first-page":"5677","author":"Hayden","year":"2001"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0040","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1093\/brain\/awn025","article-title":"Cerebral cortex and the clinical expression of Huntington's disease: complexity and heterogeneity","volume":"131","author":"Rosas","year":"2008","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0045","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1073\/pnas.85.15.5733","article-title":"Differential loss of striatal projection neurons in Huntington disease","volume":"85","author":"Reiner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0710","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/ana.410310412","article-title":"Preferential loss of striato-external pallidal projection neurons in presymptomatic Huntington's disease","volume":"31","author":"Albin","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0055","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1126\/science.2931802","article-title":"Selective sparing of a class of striatal neurons in Huntington's disease","volume":"230","author":"Ferrante","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0060","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/0006-8993(87)90694-9","article-title":"Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease","volume":"411","author":"Ferrante","year":"1987","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0065","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/0166-2236(89)90074-X","article-title":"The functional anatomy of basal ganglia disorders","volume":"12","author":"Albin","year":"1989","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0070","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1038\/ng1297-404","article-title":"Huntingtin is required for neurogenesis and is not impaired by the Huntington's disease CAG expansion","volume":"17","author":"White","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0075","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/81593","article-title":"Inactivation of Hdh in the brain and testis results in progressive neurodegeneration and sterility in mice","volume":"26","author":"Dragatsis","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0080","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1385\/MN:28:3:259","article-title":"Wild-type huntingtin plays a role in brain development and neuronal survival","volume":"28","author":"Reiner","year":"2003","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0085","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1126\/science.7618107","article-title":"Inactivation of the mouse Huntington's disease gene homolog Hdh","volume":"269","author":"Duyao","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0090","doi-asserted-by":"crossref","first-page":"14545","DOI":"10.1074\/jbc.C100044200","article-title":"Huntingtin's neuroprotective activity occurs via inhibition of procaspase-9 processing","volume":"276","author":"Rigamonti","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0095","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/0896-6273(95)90346-1","article-title":"Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons","volume":"14","author":"DiFiglia","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0100","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0968-0004(03)00168-3","article-title":"The hunt for huntingtin function: interaction partners tell many different stories","volume":"28","author":"Harjes","year":"2003","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0105","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1006\/exnr.1998.6832","article-title":"Wild-type and mutant huntingtins function in vesicle trafficking in the secretory and endocytic pathways","volume":"152","author":"Velier","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0110","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.tcb.2009.01.005","article-title":"Huntingtin as an essential integrator of intracellular vesicular trafficking","volume":"19","author":"Caviston","year":"2009","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0115","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.neuron.2010.06.027","article-title":"Huntingtin is required for mitotic spindle orientation and mammalian neurogenesis","volume":"67","author":"Godin","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0120","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.nbd.2005.02.013","article-title":"Huntingtin is cleaved by caspases in the cytoplasm and translocated to the nucleus via perinuclear sites in Huntington's disease patient lymphoblasts","volume":"20","author":"Sawa","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0125","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1042\/BJ20071619","article-title":"Huntington's disease: from pathology and genetics to potential therapies","volume":"412","author":"Imarisio","year":"2008","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0130","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1073\/pnas.0511316103","article-title":"Mutant huntingtin: nuclear translocation and cytotoxicity mediated by GAPDH","volume":"103","author":"Bae","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0135","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/hmg\/9.4.503","article-title":"Long glutamine tracts cause nuclear localization of a novel form of huntingtin in medium spiny striatal neurons in HdhQ92 and HdhQ111 knock-in mice","volume":"9","author":"Wheeler","year":"2000","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0140","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1126\/science.277.5334.1990","article-title":"Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain","volume":"277","author":"DiFiglia","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0145","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1038\/sj.mt.6300185","article-title":"Expression of mutated huntingtin fragment in the putamen is sufficient to produce abnormal movement in non-human primates","volume":"15","author":"Palfi","year":"2007","journal-title":"Mol. Ther."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0150","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/ng0298-150","article-title":"Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates","volume":"18","author":"Martindale","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0155","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.neuron.2010.06.021","article-title":"Matrix metalloproteinases are modifiers of huntingtin proteolysis and toxicity in Huntington's disease","volume":"67","author":"Miller","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0160","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuron.2010.07.011","article-title":"Hunting-ton for new proteases: MMPs as the new target?","volume":"67","author":"Johri","year":"2010","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0165","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1523\/JNEUROSCI.19-04-01189.1999","article-title":"Cellular localization of huntingtin in striatal and cortical neurons in rats: lack of correlation with neuronal vulnerability in Huntington's disease","volume":"19","author":"Fusco","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0170","doi-asserted-by":"crossref","first-page":"2061","DOI":"10.1089\/ars.2006.8.2061","article-title":"Oxidative damage in Huntington's disease pathogenesis","volume":"8","author":"Browne","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0175","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1023\/B:NERE.0000014824.04728.dd","article-title":"The energetics of Huntington's disease","volume":"29","author":"Browne","year":"2004","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0180","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1093\/hmg\/ddq306","article-title":"Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease","volume":"19","author":"Kim","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0185","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/emmm.201000102","article-title":"Mitochondrial fission and cristae disruption increase the response of cell models of Huntington's disease to apoptotic stimuli","volume":"2","author":"Costa","year":"2010","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0190","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/nm.2313","article-title":"Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity","volume":"17","author":"Song","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0195","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nm0311-245","article-title":"Hugging tight in Huntington's","volume":"17","author":"Johri","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0200","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1093\/hmg\/ddr024","article-title":"Abnormal mitochondrial dynamics, mitochondrial loss and mutant huntingtin oligomers in Huntington's disease: implications for selective neuronal damage","volume":"20","author":"Shirendeb","year":"2011","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0205","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.cell.2006.09.015","article-title":"Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration","volume":"127","author":"Cui","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0210","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.cmet.2006.10.004","article-title":"Thermoregulatory and metabolic defects in Huntington's disease transgenic mice implicate PGC-1alpha in Huntington's disease neurodegeneration","volume":"4","author":"Weydt","year":"2006","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0215","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.cell.2006.10.023","article-title":"PGC-1alpha, a new therapeutic target in Huntington's disease?","volume":"127","author":"McGill","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0220","doi-asserted-by":"crossref","first-page":"3048","DOI":"10.1093\/hmg\/ddp243","article-title":"Impaired PGC-1alpha function in muscle in Huntington's disease","volume":"18","author":"Chaturvedi","year":"2009","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0225","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1093\/hmg\/ddq229","article-title":"Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation","volume":"19","author":"Chaturvedi","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0230","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1159\/000327910","article-title":"Truncated peroxisome proliferator-activated receptor-gamma coactivator 1alpha splice variant is severely altered in Huntington's disease","volume":"8","author":"Johri","year":"2011","journal-title":"Neurodegener. Dis."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0235","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.brainresrev.2009.04.001","article-title":"Mitochondrial structural and functional dynamics in Huntington's disease","volume":"61","author":"Reddy","year":"2009","journal-title":"Brain Res. Rev."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0715","series-title":"Free Radicals in Biology and Medicine","author":"Halliwell","year":"1999"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0245","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0891-5849(90)90148-C","article-title":"Transition metals as catalysts of \u201cautoxidation\u201d reactions","volume":"8","author":"Miller","year":"1990","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0250","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3109\/10715769809065816","article-title":"The lag phase","volume":"28","author":"Cadenas","year":"1998","journal-title":"Free. Radic. Res."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0255","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.2174\/092986705774370646","article-title":"Mechanism of mitochondrial uncouplers, inhibitors, and toxins: focus on electron transfer, free radicals, and structure\u2013activity relationships","volume":"12","author":"Kovacic","year":"2005","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0260","doi-asserted-by":"crossref","first-page":"49064","DOI":"10.1074\/jbc.M407715200","article-title":"Complex III releases superoxide to both sides of the inner mitochondrial membrane","volume":"279","author":"Muller","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0265","doi-asserted-by":"crossref","first-page":"15091","DOI":"10.1016\/S0021-9258(18)98591-1","article-title":"Perhydroxyl radical (HOO) initiated lipid peroxidation. The role of fatty acid hydroperoxides","volume":"266","author":"Aikens","year":"1991","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0270","doi-asserted-by":"crossref","first-page":"C1424","DOI":"10.1152\/ajpcell.1996.271.5.C1424","article-title":"Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly","volume":"271","author":"Beckman","year":"1996","journal-title":"Am. J. Physiol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0275","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.tins.2004.07.005","article-title":"Free radicals and aging","volume":"27","author":"Barja","year":"2004","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0280","first-page":"350","article-title":"Biochemistry of free radicals: from electrons to tissues","volume":"58","author":"Boveris","year":"1998","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0285","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/15216540152845957","article-title":"The mitochondrial production of reactive oxygen species: mechanisms and implications in human pathology","volume":"52","author":"Lenaz","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0290","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1152\/physrev.00018.2001","article-title":"Free radicals in the physiological control of cell function","volume":"82","author":"Droge","year":"2002","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0295","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0891-5849(00)00252-5","article-title":"Reactive oxygen species, cell signaling, and cell injury","volume":"28","author":"Hensley","year":"2000","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0300","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/15216540252774694","article-title":"Reactive oxygen species and signal transduction","volume":"52","author":"Finkel","year":"2001","journal-title":"IUBMB Life"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0305","doi-asserted-by":"crossref","first-page":"23788","DOI":"10.1074\/jbc.M703812200","article-title":"Mitofusin 2 protects cerebellar granule neurons against injury-induced cell death","volume":"282","author":"Jahani-Asl","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0310","doi-asserted-by":"crossref","first-page":"3900","DOI":"10.1038\/sj.emboj.7601253","article-title":"Nitric oxide-induced mitochondrial fission is regulated by dynamin-related GTPases in neurons","volume":"25","author":"Barsoum","year":"2006","journal-title":"EMBO J."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0315","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/0024-3205(95)02006-5","article-title":"4-Hydroxynonenal formation during ischemia and reperfusion of rat small intestine","volume":"57","author":"Siems","year":"1995","journal-title":"Life Sci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0320","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2174\/0929867043365341","article-title":"Role of oxidant species in aging","volume":"11","author":"Stadtman","year":"2004","journal-title":"Curr. Med. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0325","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1212\/WNL.52.5.1104","article-title":"Cerebrospinal fluid F2-isoprostanes are elevated in Huntington's disease","volume":"52","author":"Montine","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0330","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1750-3639.1999.tb00216.x","article-title":"Oxidative stress in Huntington's disease","volume":"9","author":"Browne","year":"1999","journal-title":"Brain Pathol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0335","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nrn1386","article-title":"Experimental therapeutics in transgenic mouse models of Huntington's disease","volume":"5","author":"Beal","year":"2004","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0340","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1196\/annals.1427.008","article-title":"Evidence of oxidant damage in Huntington's disease: translational strategies using antioxidants","volume":"1147","author":"Stack","year":"2008","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0345","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1007\/s00415-007-0611-y","article-title":"Oxidative stress parameters in plasma of Huntington's disease patients, asymptomatic Huntington's disease gene carriers and healthy subjects: a cross-sectional study","volume":"254","author":"Klepac","year":"2007","journal-title":"J. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0350","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.freeradbiomed.2008.05.014","article-title":"Proteomic and oxidative stress analysis in human brain samples of Huntington disease","volume":"45","author":"Sorolla","year":"2008","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0355","first-page":"424","article-title":"The molecular bases of Huntington's disease: the role played by oxidative stress","volume":"49","author":"Tasset","year":"2009","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0360","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1471-4159.2005.03070.x","article-title":"Tryptophan metabolism and oxidative stress in patients with Huntington's disease","volume":"93","author":"Stoy","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0365","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.bbrc.2007.05.093","article-title":"Increased oxidative damage and mitochondrial abnormalities in the peripheral blood of Huntington's disease patients","volume":"359","author":"Chen","year":"2007","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0370","doi-asserted-by":"crossref","first-page":"5602","DOI":"10.1021\/jm200605a","article-title":"Important role of oxidative stress biomarkers in Huntington's disease","volume":"54","author":"Tunez","year":"2011","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0375","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1111\/j.1365-2990.1992.tb00824.x","article-title":"Allocortical involvement in Huntington's disease","volume":"18","author":"Braak","year":"1992","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0380","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/00005072-197404000-00008","article-title":"Studies on brain biopsies of patients with Huntington's chorea","volume":"33","author":"Tellez-Nagel","year":"1974","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0385","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0306-4522(98)00129-8","article-title":"Trinucleotide (CAG) repeat length is positively correlated with the degree of DNA fragmentation in Huntington's disease striatum","volume":"87","author":"Butterworth","year":"1998","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0390","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1523\/JNEUROSCI.15-05-03775.1995","article-title":"Evidence for apoptotic cell death in Huntington disease and excitotoxic animal models","volume":"15","author":"Portera-Cailliau","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0395","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.freeradbiomed.2010.05.016","article-title":"Protein oxidation in Huntington disease affects energy production and vitamin B6 metabolism","volume":"49","author":"Sorolla","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0400","doi-asserted-by":"crossref","first-page":"5780","DOI":"10.1074\/jbc.M704704200","article-title":"Calcium homeostasis and mitochondrial dysfunction in striatal neurons of Huntington disease","volume":"283","author":"Lim","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0405","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E","article-title":"Biochemical abnormalities and excitotoxicity in Huntington's disease brain","volume":"45","author":"Tabrizi","year":"1999","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0410","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/S0896-6273(00)80052-5","article-title":"Requirement for superoxide in excitotoxic cell death","volume":"16","author":"Patel","year":"1996","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0415","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1074\/mcp.M500090-MCP200","article-title":"Proteomic analysis of protein expression and oxidative modification in r6\/2 transgenic mice: a model of Huntington disease","volume":"4","author":"Perluigi","year":"2005","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0420","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.dnarep.2008.09.004","article-title":"Mitochondrial DNA damage is a hallmark of chemically induced and the R6\/2 transgenic model of Huntington's disease","volume":"8","author":"Acevedo-Torres","year":"2009","journal-title":"DNA Repair (Amst)"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0425","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.freeradbiomed.2010.03.017","article-title":"Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's disease","volume":"49","author":"Stack","year":"2010","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0430","doi-asserted-by":"crossref","first-page":"6182","DOI":"10.1523\/JNEUROSCI.0857-08.2008","article-title":"Full-length human mutant huntingtin with a stable polyglutamine repeat can elicit progressive and selective neuropathogenesis in BACHD mice","volume":"28","author":"Gray","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0435","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0006-8993(99)02320-3","article-title":"Oxidative stress, mitochondrial permeability transition and activation of caspases in calcium ionophore A23187-induced death of cultured striatal neurons","volume":"857","author":"Petersen","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0440","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/00001756-199011000-00004","article-title":"Ascorbic acid protects neurons from injury induced by glutamate and NMDA","volume":"1","author":"Majewska","year":"1990","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0445","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1016\/S0022-3565(25)22783-5","article-title":"Antioxidants protect against glutamate-induced cytotoxicity in a neuronal cell line","volume":"250","author":"Miyamoto","year":"1989","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0450","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2478\/v10134-010-0022-y","article-title":"Potential application of grape derived polyphenols in Huntington's disease","volume":"1","author":"Wang","year":"2010","journal-title":"Transl. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0455","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1523\/JNEUROSCI.0364-08.2008","article-title":"Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer's disease","volume":"28","author":"Wang","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0460","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/0306-4522(96)00155-8","article-title":"Protective effect of melatonin against hippocampal DNA damage induced by intraperitoneal administration of kainate to rats","volume":"73","author":"Uz","year":"1996","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0465","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-079X.2004.00163.x","article-title":"Protective effect of melatonin on 3-nitropropionic acid-induced oxidative stress in synaptosomes in an animal model of Huntington's disease","volume":"37","author":"Tunez","year":"2004","journal-title":"J. Pineal Res."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0470","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1046\/j.1471-4159.2003.01857.x","article-title":"Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies","volume":"86","author":"Santamaria","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0475","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S0014-4886(03)00214-0","article-title":"Neuroprotective effects of pyruvate in the quinolinic acid rat model of Huntington's disease","volume":"183","author":"Ryu","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0480","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0014-4886(90)90005-D","article-title":"Idebenone attenuates neuronal degeneration induced by intrastriatal injection of excitotoxins","volume":"108","author":"Miyamoto","year":"1990","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0485","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1006\/exnr.2001.7755","article-title":"A bile acid protects against motor and cognitive deficits and reduces striatal degeneration in the 3-nitropropionic acid model of Huntington's disease","volume":"171","author":"Keene","year":"2001","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0490","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1046\/j.1471-4159.2000.0751709.x","article-title":"Effect of exogenous and endogenous antioxidants on 3-nitropionic acid-induced in vivo oxidative stress and striatal lesions: insights into Huntington's disease","volume":"75","author":"Fontaine","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0495","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1006\/bbrc.2001.6164","article-title":"Direct antioxidant properties of creatine","volume":"290","author":"Lawler","year":"2002","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0500","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0014-5793(97)01045-4","article-title":"The role of creatine kinase in inhibition of mitochondrial permeability transition","volume":"414","author":"O'Gorman","year":"1997","journal-title":"FEBS Lett."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0505","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1523\/JNEUROSCI.18-01-00156.1998","article-title":"Neuroprotective effects of creatine and cyclocreatine in animal models of Huntington's disease","volume":"18","author":"Matthews","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0510","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1097\/00001756-200006260-00007","article-title":"Creatine reduces 3-nitropropionic-acid-induced cognitive and motor abnormalities in rats","volume":"11","author":"Shear","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0515","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ana.410360613","article-title":"Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate","volume":"36","author":"Beal","year":"1994","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0520","doi-asserted-by":"crossref","first-page":"8892","DOI":"10.1073\/pnas.95.15.8892","article-title":"Coenzyme Q10 administration increases brain mitochondrial concentrations and exerts neuroprotective effects","volume":"95","author":"Matthews","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0525","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/j.1471-4159.2009.06074.x","article-title":"Combination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases","volume":"109","author":"Yang","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0530","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3109\/01480541003642050","article-title":"Possible nitric oxide modulation in protective effect of FK-506 against 3-nitropropionic acid-induced behavioral, oxidative, neurochemical, and mitochondrial alterations in rat brain","volume":"33","author":"Kumar","year":"2010","journal-title":"Drug Chem. Toxicol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0535","doi-asserted-by":"crossref","first-page":"2522","DOI":"10.1016\/j.fct.2009.07.011","article-title":"Effect of lycopene and epigallocatechin-3-gallate against 3-nitropropionic acid induced cognitive dysfunction and glutathione depletion in rat: a novel nitric oxide mechanism","volume":"47","author":"Kumar","year":"2009","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0540","doi-asserted-by":"crossref","first-page":"e5757","DOI":"10.1371\/journal.pone.0005757","article-title":"Neuroprotective effects of the triterpenoid, CDDO methyl amide, a potent inducer of Nrf2-mediated transcription","volume":"4","author":"Yang","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0545","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0891-5849(96)00269-9","article-title":"Neuroprotection by the metabolic antioxidant alpha-lipoic acid","volume":"22","author":"Packer","year":"1997","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0550","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/j.bbagen.2009.07.026","article-title":"Alpha-lipoic acid as a dietary supplement: molecular mechanisms and therapeutic potential","volume":"1790","author":"Shay","year":"2009","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0555","doi-asserted-by":"crossref","first-page":"3371","DOI":"10.1097\/00001756-200110290-00044","article-title":"Lipoic acid improves survival in transgenic mouse models of Huntington's disease","volume":"12","author":"Andreassen","year":"2001","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0560","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/ana.1085","article-title":"Dichloroacetate exerts therapeutic effects in transgenic mouse models of Huntington's disease","volume":"50","author":"Andreassen","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0565","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1046\/j.1471-4159.2003.t01-1-01868.x","article-title":"Increased survival and neuroprotective effects of BN82451 in a transgenic mouse model of Huntington's disease","volume":"86","author":"Klivenyi","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0570","doi-asserted-by":"crossref","first-page":"10671","DOI":"10.1073\/pnas.162362299","article-title":"Tauroursodeoxycholic acid, a bile acid, is neuroprotective in a transgenic animal model of Huntington's disease","volume":"99","author":"Keene","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0575","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1002\/ana.1028","article-title":"Potential for creatine and other therapies targeting cellular energy dysfunction in neurological disorders","volume":"49","author":"Tarnopolsky","year":"2001","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0580","doi-asserted-by":"crossref","first-page":"4389","DOI":"10.1523\/JNEUROSCI.20-12-04389.2000","article-title":"Neuroprotective effects of creatine in a transgenic mouse model of Huntington's disease","volume":"20","author":"Ferrante","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0585","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1006\/nbdi.2001.0406","article-title":"Creatine increases survival and delays motor symptoms in a transgenic animal model of Huntington's disease","volume":"8","author":"Andreassen","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0590","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1523\/JNEUROSCI.22-05-01592.2002","article-title":"Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's disease","volume":"22","author":"Ferrante","year":"2002","journal-title":"J. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0595","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.biopha.2009.06.020","article-title":"Neuroprotective effects of l-carnitine in a transgenic animal model of Huntington's disease","volume":"64","author":"Vamos","year":"2010","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0600","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/0022-510X(92)90191-M","article-title":"Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex","volume":"108","author":"Beal","year":"1992","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0605","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.cub.2011.04.028","article-title":"The kynurenine pathway modulates neurodegeneration in a Drosophila model of Huntington's disease","volume":"21","author":"Campesan","year":"2011","journal-title":"Curr. Biol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0610","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.cell.2011.05.020","article-title":"Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration","volume":"145","author":"Zwilling","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0615","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1176\/ajp.152.12.1771","article-title":"Trial of d-alpha-tocopherol in Huntington's disease","volume":"152","author":"Peyser","year":"1995","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0620","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1002\/mds.870110510","article-title":"A controlled trial of idebenone in Huntington's disease","volume":"11","author":"Ranen","year":"1996","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0625","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1212\/01.wnl.0000194318.74946.b6","article-title":"Creatine in Huntington disease is safe, tolerable, bioavailable in brain and reduces serum 8OH2'dG","volume":"66","author":"Hersch","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0630","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00726-011-0851-0","article-title":"Neuroprotective effects of creatine","volume":"40","author":"Beal","year":"2011","journal-title":"Amino Acids"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0720","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1002\/mds.22408","article-title":"Safety and tolerability of high-dosage coenzyme Q10 in Huntington's disease and healthy subjects","volume":"25","author":"Hyson","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0640","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.cell.2006.09.024","article-title":"Suppression of reactive oxygen species and neurodegeneration by the PGC-1 transcriptional coactivators","volume":"127","author":"St-Pierre","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0645","doi-asserted-by":"crossref","first-page":"e101","DOI":"10.1371\/journal.pbio.0030101","article-title":"PGC-1alpha deficiency causes multi-system energy metabolic derangements: muscle dysfunction, abnormal weight control and hepatic steatosis","volume":"3","author":"Leone","year":"2005","journal-title":"PLoS Biol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0650","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.cell.2004.09.013","article-title":"Defects in adaptive energy metabolism with CNS-linked hyperactivity in PGC-1alpha null mice","volume":"119","author":"Lin","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0655","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pbb.2010.04.018","article-title":"Pioglitazone ameliorates behavioral, biochemical and cellular alterations in quinolinic acid induced neurotoxicity: possible role of peroxisome proliferator activated receptor-Upsilon (PPARUpsilon) in Huntington's disease","volume":"96","author":"Kalonia","year":"2010","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0660","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/hmg\/ddq322","article-title":"Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma","volume":"19","author":"Chiang","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0665","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.neuint.2005.09.002","article-title":"Effect of coenzyme Q10 and vitamin E on brain energy metabolism in the animal model of Huntington's disease","volume":"48","author":"Kasparova","year":"2006","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0670","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.ejphar.2010.02.031","article-title":"Targeting oxidative stress attenuates malonic acid induced Huntington like behavioral and mitochondrial alterations in rats","volume":"634","author":"Kalonia","year":"2010","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0675","first-page":"263","article-title":"l-acetyl-carnitine in Huntington's disease: double-blind placebo controlled crossover study of drug effects on movement disorder and dementia","volume":"5","author":"Goety","year":"1990","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0680","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/jnr.22240","article-title":"NAD(P)H oxidase contributes to neurotoxicity in an excitotoxic\/prooxidant model of Huntington's disease in rats: protective role of apocynin","volume":"88","author":"Maldonado","year":"2010","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0685","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s00401-010-0788-5","article-title":"Modulation of lipid peroxidation and mitochondrial function improves neuropathology in Huntington's disease mice","volume":"121","author":"Lee","year":"2011","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0690","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1179\/1476830511Y.0000000005","article-title":"Olive oil reduces oxidative damage in a 3-nitropropionic acid-induced Huntington's disease-like rat model","volume":"14","author":"Tasset","year":"2011","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.bbadis.2011.11.014_bb0695","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1016\/j.neuroscience.2006.05.043","article-title":"Combined minocycline plus pyruvate treatment enhances effects of each agent to inhibit inflammation, oxidative damage, and neuronal loss in an excitotoxic animal model of Huntington's disease","volume":"141","author":"Ryu","year":"2006","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbadis.2011.11.014_bb0700","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1089\/jmf.2008.0028","article-title":"Possible neuroprotective effect of Withania somnifera root extract against 3-nitropropionic acid-induced behavioral, biochemical, and mitochondrial dysfunction in an animal model of Huntington's disease","volume":"12","author":"Kumar","year":"2009","journal-title":"J. Med. Food"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443911002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,14]],"date-time":"2025-03-14T06:47:25Z","timestamp":1741934845000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443911002742"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":140,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S0925443911002742"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2011.11.014","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}